Hycamtin (Topotecan Capsules) and Interstitial lung disease
Result of checking the interaction of drug Hycamtin (Topotecan Capsules) and disease Interstitial lung disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Fatal cases of interstitial lung disease (ILD) have occurred with the use of topotecan. Risk factors include a history of ILD, pulmonary fibrosis, lung cancer, thoracic radiation, and use of pneumotoxic drugs and/or colony stimulating factors. It is recommended to monitor patients for pulmonary symptoms indicative of ILD and permanently discontinue treatment for confirmed ILD.
Generic Name: topotecan
Brand Name: Hycamtin
Synonyms: Hycamtin (oral/injection), Hycamtin